Use of toll-like receptor assays to detect and identify microbial contaminants in biological products

Journal of Clinical Microbiology

Volumn 47, Issue 11, 2009, Pages 3427-3434

  Huang, Li Yun ^a   DuMontelle, James L ^b   Zolodz, Melissa ^b   Deora, Aparna ^b   Mozier, Ned M ^b   Golding, Basil ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; FLAGELLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTICLE; B LYMPHOCYTE ACTIVATION; BACTERIUM CONTAMINATION; CELL STRAIN HEK293; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOASSAY; MOLECULAR SIZE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA;

BIOLOGICAL PRODUCTS; BLOTTING, WESTERN; CELL LINE; CYTOKINES; DRUG CONTAMINATION; ESCHERICHIA COLI; FLAGELLIN; HUMANS; IMMUNOASSAY; LIPOPOLYSACCHARIDES; MASS SPECTROMETRY; NF-KAPPA B; SALMONELLA TYPHIMURIUM; TOLL-LIKE RECEPTORS;

ESCHERICHIA COLI; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 70449637765     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00373-09     Document Type: Article

References (28)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Anonymous. 2009. Current good manufacturing practice for finished pharmaceuticals: special testing requirements. 21CFR211.167. U.S. Code of Federal Regulations. Government Printing Office, Washington, DC.
3. Anonymous. 2009. General biological products standards: purity. 21CFR610.13. U.S. Code of Federal Regulations. Government Printing Office, Washington, DC.
4. DHHS. 2008. Availability of the ICCVAM test method evaluation report and final background review document, and transmittal of ICCVAM test method recommendations to federal agencies. Fed. Regist. 73:71003-71004.
5. Feng, P., R. J. Sugasawara, and A. Schantz. 1990. Identification of a common enterobacterial flagellin epitope with a monoclonal antibody. J. Gen. Microbiol. 136:337-342.
6. Giron, J. A. 1995. Expression of flagella and motility by Shigella. Mol. Microbiol. 18:63-75.
7. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
8. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103. (Pubitemid 32391041)
9. Hoffmann, S., A. Peterbauer, S. Schindler, S. Fennrich, S. Poole, Y. Mistry, T. Montag-Lessing, I. Spreitzer, B. Loschner, M. van Aalderen, R. Bos, M. Gommer, R. Nibbeling, G. Werner-Felmayer, P. Loitzl, T. Jungi, M. Brcic, P. Brugger, E. Frey, G. Bowe, J. Casado, S. Coecke, J. de Lange, B. Mogster, L. M. Naess, I. S. Aaberge, A. Wendel, and T. Hartung. 2005. International validation of novel pyrogen tests based on human monocytoid cells. J. Immunol. Methods 298:161-173. (Pubitemid 40545102)
10. ICCVAM. 2008. The test method evaluation report (TMER). NIH publication 08-6392. National Institutes of Health, Bethesda, MD.
11. ICCVAM and NICEATM. 2007. Independent peer review panel report: five in vitro test methods proposed for assessing potential pyrogenicity of pharmaceuticals and other products. National Institutes of Health, Bethesda, MD.
12. Ishii, K. J., S. Koyama, A. Nakagawa, C. Coban, and S. Akira. 2008. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3:352-363.
13. Janeway, C. A., Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54(Pt 1):1-13.
14. Kumagai, Y., O. Takeuchi, and S. Akira. 2008. Pathogen recognition by innate receptors. J. Infect. Chemother. 14:86-92.
15. Kumar, H., T. Kawai, and S. Akira. 2009. Pathogen recognition in the innate immune response. Biochem. J. 420:1-16.
16. Louis, N., C. Evelegh, and F. L. Graham. 1997. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233:423-429. (Pubitemid 27314828)
17. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397.
18. Reed, K. A., M. E. Hobert, C. E. Kolenda, K. A. Sands, M. Rathman, M. O'Connor, S. Lyons, A. T. Gewirtz, P. J. Sansonetti, and J. L. Madara. 2002. The Salmonella typhimurium flagellar basal body protein FliE is required for flagellin production and to induce a proinflammatory response in epithelial cells. J. Biol. Chem. 277:13346-13353.
19. Schindler, S., I. Spreitzer, B. Loschner, S. Hoffmann, K. Hennes, M. Halder, P. Brugger, E. Frey, T. Hartung, and T. Montag. 2006. International validation of pyrogen tests based on cryopreserved human primary blood cells. J. Immunol. Methods 316:42-51. (Pubitemid 44573216)
20. Schoenhals, G., and C. Whitfield. 1993. Comparative analysis of flagellin sequences from Escherichia coli strains possessing serologically distinct flagellar filaments with a shared complex surface pattern. J. Bacteriol. 175: 5395-5402.
21. Shaw, G., S. Morse, M. Ararat, and F. L. Graham. 2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16:869-871.
22. Simon, R., and C. E. Samuel. 2007. Activation of NF-kappaB-dependent gene expression by Salmonella flagellins FliC and FljB. Biochem. Biophys. Res. Commun. 355:280-285.
23. Smith, M. F., Jr., A. Mitchell, G. Li, S. Ding, A. M. Fitzmaurice, K. Ryan, S. Crowe, and J. B. Goldberg. 2003. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 278: 32552-32560.
24. Takeshita, F., C. A. Leifer, I. Gursel, K. J. Ishii, S. Takeshita, M. Gursel, and D. M. Klinman. 2001. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167:3555-3558. (Pubitemid 32910795)
25. Taktak, Y. S., S. Selkirk, A. F. Bristow, A. Carpenter, C. Ball, B. Rafferty, and S. Poole. 1991. Assay of pyrogens by interleukin-6 release from monocytic cell lines. J. Pharm. Pharmacol. 43:578-582.
26. Uematsu, S., and S. Akira. 2008. Toll-Like receptors (TLRs) and their ligands. Handb. Exp. Pharmacol. 2008:1-20.
27. Wolfert, M. A., T. F. Murray, G. J. Boons, and J. N. Moore. 2002. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 277:39179-39186.
28. Ziegler-Heitbrock, H. W., E. Thiel, A. Futterer, V. Herzog, A. Wirtz, and G. Riethmuller. 1988. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 41:456-461.